Gujarat Themis Biosyn Limited (GUJTHEM) — Insider Trading

· NSE 🔴 High Importance Neutral
📢 Key Event
Promoter proposes inter-se share acquisition from promoter group
🔄 What Changed
Withdrawal of prior disclosure and re-filing under revised timeline
🔮 What's Next
Acquisition to occur between 21.07.2026 and 31.07.2026
💡 Investor Takeaway
This is a minor promoter-to-promoter share transfer with no material change in holding structure or shareholder value.

Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares at Rs. 382 per share (total value up to Rs. 20 crores) from Pharmaceutical Business Group (India) Limited, representing up to 0.50% of the company's share capital. The transaction is an inter-se transfer among promoters and is exempt from open offer under SEBI SAST Regulation 10(1)(a)(ii). The filing withdraws a prior disclosure made on 1 July 2026 due to missed deadlines, and confirms compliance with all regulatory requirements including price limits and disclosure norms.

📄 View Original Announcement (PDF)

About Gujarat Themis Biosyn Limited (GUJTHEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,034.98 Cr P/E: 84.4

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

📊 More GUJTHEM filings

See all GUJTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day